Requirement of Vascular Integrin α v β 3 for Angiogenesis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Angiogenesis depends on the adhesive interactions of vascular cells. The adhesion receptor integrin α v β 3 was identified as a marker of angiogenic vascular tissue. Integrin α v β 3 was expressed on blood vessels in human wound granulation tissue but not in normal skin, and it showed a fourfold increase in expression during angiogenesis on the chick chorioallantoic membrane. In the latter assay, a monoclonal antibody to α v β 3 blocked angiogenesis induced by basic fibroblast growth factor, tumor necrosis factor-α, and human melanoma fragments but had no effect on preexisting vessels. These findings suggest that α v β 3 may be a useful therapeutic target for diseases characterized by neovascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the integrin a v b 3 is expressed on blood vessels in human wound granulation tissue but not in normal skin”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
In the citing paper
“antibodies against this integrin block angiogenesis induced by FGF and TNF-a without affecting preexisting blood vessels”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationCell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
Lawler, J., Weinstein, R., & Hynes, R. O. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2351 · Cited by 474
Adams, J. C., & Watt, F. M. (1990) · Cell · doi:10.1016/0092-8674(90)90175-e · Cited by 448
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationLeavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Self-citationInvolvement of integrin alpha V gene expression in human melanoma tumorigenicity.
Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., & Cheresh, D. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115811 · Cited by 378
Self-citation
Research works printed but not linked: 1
- FOLKMAN, J, SEMINARS CANCER BIOL 3: 65 (1992).
Cited by
Items 801–900 of 1,011
Wu, C., Hughes, P. E., Ginsberg, M. H., & McDonald, J. A. (1996) · Cell Adhesion and Communication · doi:10.3109/15419069609014219 · Cited by 103
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization
Lambert, V., Munaut, C., Noël, A., Frankenne, F., Bajou, K., Gerard, R. D., Carmeliet, P., Defresne, M. P., Foidart, J., & Rakic, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0393com · Cited by 103
Rapraeger, A. C. (2013) · The FEBS Journal · doi:10.1111/febs.12160 · Cited by 103
Roles of αv integrins in vascular biology and pulmonary pathology
Sheppard, D. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.06.017 · Cited by 102
Role of vascular permeability factor/vascular endothelial growth factor in eye disease
Schlingemann, R. O., & van Hinsbergh, V. W. M. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.6.501 · Cited by 102
Peptide‐based Molecules in Angiogenesis
D’Andrea, L. D., Gatto, A. D., Pedone, C., & Benedetti, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00356.x · Cited by 102
Wei, L., Ye, Y., Wadas, T. J., Lewis, J. S., Welch, M. J., Achilefu, S., & Anderson, C. J. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.12.008 · Cited by 102
Potential non-glycoprotein IIb/IIIa effects of abciximab
Coller, B. S. (1999) · American Heart Journal · doi:10.1053/hj.1999.v138.99078 · Cited by 102
Watanabe, Y., & Dvorak, H. F. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3583 · Cited by 101
Microfilaments and microtubules maintain endothelial integrity
Lee, T. J., & Gotlieb, A. I. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10250 · Cited by 101
Su, Z.-F., Liu, G., Gupta, S., Zhu, Z., Rusckowski, M., & Hnatowich, D. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0155566 · Cited by 101
Coller, B. S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615850 · Cited by 101
New insights in synovial angiogenesis
Szekanecz, Z., Besenyei, T., Paragh, G., & Koch, A. E. (2009) · Joint Bone Spine · doi:10.1016/j.jbspin.2009.05.011 · Cited by 101
A Novel Method for Direct Site-Specific Radiolabeling of Peptides Using [18F]FDG
Namavari, M., Cheng, Z., Zhang, R., De, A., Levi, J., Hoerner, J. K., Yaghoubi, S. S., Syud, F. A., & Gambhir, S. S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800422b · Cited by 101
Rodan, G. A. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44614.x · Cited by 100
Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro
Butzal, M., Loges, S., Schweizer, M., Fischer, U., Gehling, U. M., HOSSFELD, D. K., & Fiedler, W. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.002 · Cited by 100
β1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond
Jahangiri, A., Aghi, M. K., & Carbonell, W. S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1742 · Cited by 100
Duque, H., & Baxt, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2500-2511.2003 · Cited by 100
Angiogenic growth factors in neural embryogenesis and neoplasia.
Zagzag, D. (1995) · Europe PMC (PubMed Central) · Cited by 100
Frochot, C., Stasio, B. D., Vanderesse, R., Belgy, M.-J., Dodeller, M., Guillemin, F. H., Viriot, M., & Barberi‐Heyob, M. (2006) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2006.11.005 · Cited by 100
Human three-dimensional fibroblast cultures express angiogenic activity
Pinney, E., Liu, K., Sheeman, B., & Mansbridge, J. N. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<74::aid-jcp9>3.0.co;2-g · Cited by 100
A Triple‐Targeted Ultrasound Contrast Agent Provides Improved Localization to Tumor Vasculature
Warram, J. M., Sorace, A. G., Saini, R., Umphrey, H. R., Zinn, K. R., & Hoyt, K. (2011) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2011.30.7.921 · Cited by 100
Rapid solid phase synthesis and biodistribution of 18F-labelled linear peptides
Sutcliffe-Goulden, J., O'Doherty, M. J., Marsden, P. K., Hart, I. R., Marshall, J. F., & Bansal, S. S. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0756-3 · Cited by 100
Specific Binding of Integrin αvβ3 to the Fibrinogen γ and α E Chain C-Terminal Domains
Yokoyama, K., Zhang, X.-P., Medved, L. V., & Takada, Y. (1999) · Biochemistry · doi:10.1021/bi9827619 · Cited by 99
Naik, M. U., Vuppalanchi, D., & Naik, U. P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000093982.84451.87 · Cited by 99
Jin, Y., Park, I., Hong, I., Byun, H.-J., Choi, J., Kim, Y., & Lee, H. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.08.012 · Cited by 99
Rader, C. M., Sinha, S. C., Popkov, M., Lerner, R. A., & Barbas, C. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931308100 · Cited by 99
A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries
Rader, C. M., Cheresh, D. A., & Barbas, C. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8910 · Cited by 99
Self-citationNemeth, J. A., Cher, M. L., Zhao, Z., Mullins, C. M., Bhagat, S., & Trikha, M. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025461507027 · Cited by 99
FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis
Sahni, A., Khorana, A. A., Baggs, R. B., Peng, H., & Francis, C. W. (2005) · Blood · doi:10.1182/blood-2005-06-2460 · Cited by 99
Endothelial cell integrin α5β1 expression is modulated by cytokines and during migration in vitro
Collo, G., & Pepper, M. S. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.4.569 · Cited by 98
Choi, H., & Moon, A. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1051-1 · Cited by 98
Neurite Outgrowth in Fibrin Gels Is Regulated by Substrate Stiffness
Man, A. J., Davis, H. E., Itoh, A., Leach, J. K., & Bannerman, P. G. C. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0030 · Cited by 98
Kolodziej, C. M., Kim, S. H., Broyer, R. M., Saxer, S., Decker, C. G., & Maynard, H. D. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205524x · Cited by 98
The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
Gu, Y., Dong, B., Xu, H., Qiu, Z., Zhang, J., Zhang, M., Liu, H., Pang, X., & Cui, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106694 · Cited by 98
Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation
Pinon, P., & Wehrle‐Haller, B. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00806.x · Cited by 98
Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast
Rice, A. J., & Quinn, C. M. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.8.569 · Cited by 98
Angiogenesis and the skin: A primer
Arbiser, J. L. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90444-2 · Cited by 97
Hotchkiss, K. A., Ashton, A. W., & Schwartz, E. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212670200 · Cited by 97
Alterations in Cell-Extracellular Matrix Interactions during Progression of Cancers
Jinka, R., Kapoor, R., Sistla, P. G., Raj, T. A., & Pande, G. (2012) · International Journal of Cell Biology · doi:10.1155/2012/219196 · Cited by 97
Focal adhesion kinase: protein interactions and cellular functions.
Abbi, S., & Guan, J. (2002) · PubMed · doi:10.14670/hh-17.1163 · Cited by 97
Nanomedicine – advantages for their use in rheumatoid arthritis theranostics
Xiao, S., Tang, Y., Lv, Z., Lin, Y., & Chen, L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.008 · Cited by 97
Unoccupied αvβ3Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal
Zhao, H., Ross, F. P., & Teitelbaum, S. L. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0161 · Cited by 97
Genes that Regulate Metastasis and Angiogenesis
Webb, C. P., & Woude, G. F. V. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006466605356 · Cited by 97
Peptide-targeted PEG-liposomes in anti-angiogenic therapy
Janssen, A., Schiffelers, R. M., ten Hagen, T. L. M., Koning, G. A., Schraa, A. J., Kok, R. J., Storm, G., & Molema, G. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00682-8 · Cited by 97
Hamilton, A. M., Aidoudi-Ahmed, S., Sharma, S., Kotamraju, V. R., Foster, P. J., Sugahara, K. N., Ruoslahti, E., & Rutt, B. K. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1279-x · Cited by 97
Positron emission tomography (PET): Expanding the horizons of oncology drug development
Hammond, L. A., Denis, L., Salman, U. A., Jerabek, P., Thomas, C. R., & Kuhn, J. G. (2003) · Investigational New Drugs · doi:10.1023/a:1025468611547 · Cited by 97
Chouhan, D., Thatikonda, N., Nilebäck, L., Widhe, M., Hedhammar, M., & Mandal, B. B. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05853 · Cited by 97
Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation
Cox, N., Kintzing, J. R., Smith, M. A., Grant, G. A., & Cochran, J. R. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201603488 · Cited by 97
Molecular Properties of Fibrin-Based Matrices for Promotion of Angiogenesis in Vitro
Hall, H., Baechi, T., & Hubbell, J. A. (2001) · Microvascular Research · doi:10.1006/mvre.2001.2348 · Cited by 96
Domain IVa of laminin α5 chain is cell‐adhesive and binds β1 and αVβ3 integrins through Arg‐Gly‐Asp
Sasaki, T., & Timpl, R. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03167-2 · Cited by 96
Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™
Mulgrew, K., Kinneer, K., Yao, X.-T., Ward, B. K., Damschroder, M. M., Walsh, B., Mao, S.-Y., Gao, C., Kiener, P. A., Coats, S., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0356 · Cited by 96
Bird, I. N., Taylor, V., Newton, J. P., Spragg, J. H., Simmons, D. L., Salmon, M., & Buckley, C. D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.12.1989 · Cited by 96
Ivaska, J., & Heino, J. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0857-z · Cited by 96
Maubant, S., Saint-Dizier, D., Boutillon, M., Perron-Sierra, F., Casara, P. J., Hickman, J. A., Tucker, G. C., & Van Obberghen-Schilling, E. (2006) · Blood · doi:10.1182/blood-2006-05-023580 · Cited by 96
Osteopontin is required for full expression of the transformed phenotype by the ras oncogene
Wu, Y., Denhardt, D. T., & Rittling, S. R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1200 · Cited by 96
Zhang, L., Su, H., Wang, H., Li, Q., Li, X., Zhou, C., Xu, J., Chai, Y., Liang, X., Xiong, L., et al. (2019) · Theranostics · doi:10.7150/thno.30523 · Cited by 96
Wang, C., Su, P., Du, X., Kuo, M., Lin, C., Yang, C., Chan, H., Chang, S., Kuo, C. J., Kyunga, S., et al. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21990 · Cited by 96
Park, E. J., Myint, P. K., Ito, A., Appiah, M. G., Darkwah, S. O., Kawamoto, E., & Shimaoka, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.588066 · Cited by 96
The role of PET/CT in cervical cancer
Herrera, F. G., & Prior, J. O. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00034 · Cited by 96
Akinori, U. E. D. A., Koga, M., Ikeda, M., Susumu, K. U. D. O., & Tanishita, K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00400.2003 · Cited by 96
Iizuka, M., Abé, M., Shiiba, K., Sasaki, I., & Sato, Y. (2004) · Journal of Vascular Research · doi:10.1159/000079832 · Cited by 96
Enhanced Nanodrug Delivery to Solid Tumors Based on a Tumor Vasculature‐Targeted Strategy
Song, C., Zhang, Y., Li, C., Chen, G., Kang, X., & Wang, Q. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600417 · Cited by 95
Naik, M. U., & Naik, U. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02771 · Cited by 95
Modulation of prostate cancer growth in bone microenvironments
Edlund, M., Sung, S., & Chung, L. W. K. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10702 · Cited by 95
Molecular ultrasound assessment of tumor angiogenesis
Deshpande, N., Pysz, M. A., & Willmann, J. K. (2010) · Angiogenesis · doi:10.1007/s10456-010-9175-z · Cited by 95
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
Huang, M., Zhai, B., Fan, Y. B., Sun, J., Shi, Y., Zhang, X., Zou, J., Wang, J., & Guo, D. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s410688 · Cited by 95
In Vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in an Orthotopic Glioblastoma Model
Hsu, A. R., Hou, L. C., Veeravagu, A., Greve, J. M., Vogel, H. S., Tse, V., & Chen, X. S. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0059-y · Cited by 95
Thrombin induces neoangiogenesis in the chick chorioallantoic membrane
Caunt, M., Huang, Y.-Q., Brooks, P. C., & Karpatkin, S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00426.x · Cited by 95
Self-citationFibronectin and Other Adhesive Glycoproteins
Xu, J., & Mosher, D. F. (2010) · Springer eBooks · doi:10.1007/978-3-642-16555-9_2 · Cited by 94
Human Malignant Glioma Therapy Using Anti-αVβ3 Integrin Agents
Chatterjee, S., Matsumura, A., Schradermeier, J., & Gillespie, G. Y. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006444300504 · Cited by 94
Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives
Eichhorn, M., Strieth, S., & Dellian, M. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.03.001 · Cited by 94
Platelet‐Activation Mechanisms and Vascular Remodeling
Rubenstein, D. A., & Yin, W. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170049 · Cited by 94
Quigley, N. G., Steiger, K., Hoberück, S., Czech, N., Zierke, M. A., Kossatz, S., Pretze, M., Richter, F., Weichert, W., Pox, C. P., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05559-x · Cited by 94
Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targeting
Mitra, A., Coleman, T., Borgman, M. P., Nan, A., Ghandehari, H., & Line, B. R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.014 · Cited by 94
Haubner, R., Maschauer, S., & Prante, O. (2014) · BioMed Research International · doi:10.1155/2014/871609 · Cited by 94
Liu, J., Long, H., Zeuschner, D., Räder, A. F. B., Polacheck, W. J., Kessler, H., Sorokin, L. M., & Trappmann, B. (2021) · Nature Communications · doi:10.1038/s41467-021-23644-5 · Cited by 93
Involvement of CTGF, a Hypertrophic Chondrocyte-Specific Gene Product, in Tumor Angiogenesis
Shimo, T., Nakanishi, T., Nishida, T., Asano, M., Sasaki, A., Kanyama, M., Kuboki, T., Matsumura, T., & Takigawa, M. (2001) · Oncology · doi:10.1159/000055339 · Cited by 93
Biological and molecular properties of a new αvβ3/αvβ5 integrin antagonist
Belvisi, L., Riccioni, T., Marcellini, M., Vesci, L., Chiarucci, I., Efrati, D., Potenza, D., Scolastico, C., Manzoni, L., Lombardo, K., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0120 · Cited by 93
Imaging of angiogenesis using Cadence™ contrast pulse sequencing and targeted contrast agents
Stieger‐Vanegas, S. M., Dayton, P. A., Borden, M. A., Caskey, C. F., Griffey, S. M., Wisner, E. R., & Ferrara, K. W. (2008) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.224 · Cited by 93
PDK1: A signaling hub for cell migration and tumor invasion
Gagliardi, P. A., di Blasio, L., & Primo, L. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.07.003 · Cited by 93
Cooke, V. G., Naik, M. U., & Naik, U. P. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000234923.79173.99 · Cited by 93
Hu, D. D., Barbas, C. F., & Smith, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21745 · Cited by 93
Cutaneous vascular patterns in psoriasis
Micali, G., Lacarrubba, F., Musumeci, M. L., Massimino, D., & Nasca, M. R. (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2009.04287.x · Cited by 92
The Embryonic Angiogenic Factor Del1 Accelerates Tumor Growth by Enhancing Vascular Formation
Aoka, Y., Johnson, F. L., Penta, K., Hirata, K., Hidai, C., Schatzman, R. C., Varner, J. A., & Quertermous, T. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2414 · Cited by 92
Knockdown of CD146 reduces the migration and proliferation of human endothelial cells
Kang, Y., Wang, F., Feng, J., Yang, D., Yang, X., & Yan, X. (2006) · Cell Research · doi:10.1038/sj.cr.7310039 · Cited by 92
Nip, J., Rabbani, S. A., Shibata, H. R., & Brodt, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117897 · Cited by 91
A Targeted and Stable Polymeric Nanoformulation Enhances Systemic Delivery of mRNA to Tumors
Chen, Q., Qi, R., Chen, X., Yang, X., Wu, S., Xiao, H., & Dong, W. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.006 · Cited by 91
Yoon, H., Kang, K. W., Chun, I. K., Cho, N., Im, S., Jeong-Yu, S., Lee, S., Jung, K. C., Lee, Y., Jeong, J. M., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2744-4 · Cited by 91
The αvβ3 Integrin Regulates α5β1-mediated Cell Migration toward Fibronectin
Simon, K. O., Nutt, E. M., Abraham, D. G., Rodan, G. A., & Duong, L. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29380 · Cited by 91
Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin.
Mundhenke, C., Thomas, J. P., Wilding, G., Lee, F. T., Kelzc, F., Chappell, R. J., Neider, R. S., Sebree, L., & Friedl, A. (2001) · PubMed · Cited by 91
Belkin, A. M., Tsurupa, G., Zemskov, E., Veklich, Y., Weisel, J. W., & Medved, L. (2005) · Blood · doi:10.1182/blood-2004-10-4089 · Cited by 90
Sun, J., Jiang, L., Lin, Y., Gerhard, E. M., Jiang, X., Li, L., Yang, J. Y., & Gu, Z. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s122859 · Cited by 90
Kluza, E., Jacobs, I., Hectors, S. J. C. G., Mayo, K. H., Griffioen, A. W., Strijkers, G. J., & Nicolay, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.032 · Cited by 90
Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose.
Takahashi, Y., Teshima, T., Kawaguchi, N., Hamada, Y., Mori, S., Madachi, A., Ikeda, S., Mizuno, H., Ogata, T., Nojima, K., et al. (2003) · PubMed · Cited by 90
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases
Ross, M. H., Esser, A. K., Fox, G. C., Schmieder, A. H., Yang, X., Hu, G., Pan, D., Su, X., Xu, Y., Novack, D. V., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1225 · Cited by 90
Tumor‐targeted nanotherapeutics: overcoming treatment barriers for glioblastoma
Wadajkar, A. S., Dancy, J. G., Hersh, D. S., Anastasiadis, P., Tran, N. L., Woodworth, G. F., Winkles, J. A., & Kim, A. J. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1439 · Cited by 90
Spanggaard, I., Snoj, M., Cavalcanti, A., Bouquet, C., Serša, G., Robert, C., Čemažar, M., Dam, E., Vasseur, B., Attali, P., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2012.240 · Cited by 90
Bisanz, K. M., Yu, J., Edlund, M., Spohn, B., Hung, M., Chung, L. W. K., & Hsieh, C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.05.012 · Cited by 90
Targeting Microvasculature for Neuroprotection after SCI
Fassbender, J. M., Whittemore, S. R., & Hagg, T. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0029-1 · Cited by 90
Metadata
- Authors
- Brooks, P. C., Clark, R. A. F., & Cheresh, D. A.
- Affiliations
- Scripps Research Institute (US)
- Stony Brook University (US)
- Venue
- Science
- Published
- 1994-04-22
- Volume
- 264
- Issue
- 5158
- Pages
- 569-571
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029773366
- Cited by
- 3,020
- References
- 22
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 50 · 2023: 36 · 2022: 57 · 2021: 60 · 2020: 54 · 2019: 60 · 2018: 69 · 2017: 62 · 2016: 91 · 2015: 74 · 2014: 102 · 2013: 124 · 2012: 104
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50286, CA-45726, R01CA045726)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ3, angiogenesis, chorioallantoic membrane, basic fibroblast growth factor, TNF-α, melanoma, monoclonal antibodies, neovascularization, therapeutic target
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Vessels, Chick Embryo, Granulation Tissue, Humans, Laminin, Melanoma, Neovascularization, Pathologic, Skin, Tumor Necrosis Factor-alpha, von Willebrand Factor, Integrins, Receptors, Cytoadhesin, Fibroblast Growth Factor 2, Receptors, Vitronectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.